Clinical Trials Arena May 2, 2024
Justine Ra

Experts say that Project Optimus is a necessary reform in the oncology space, but one that should be applied with caution.

Alongside the multitude of guidance documents, recent years have seen the US Food and Drug Administration (FDA) ramp up workshops and project implementation efforts in a bid to drive innovation in drug development. Agency eyes have zeroed in on oncology, with the FDA Oncology Center of Excellence (OCE) introducing frameworks such as Project Optimus to reform the dose optimisation and dose selection paradigm in oncology drug development.

While the framework of Optimus is not new to drug development, it is relatively new to oncology. In non-deadly indications, researchers have been employing the framework for quite some time because the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Clinical Trials, FDA, Govt Agencies, Pharma, Pharma / Biotech, Trends
Sun Pharma buys Checkpoint and its new cancer drug
3 ways to accelerate development and de-risk cell and gene therapy manufacturing
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
CVS Plans Chain of Smaller-Footprint Pharmacy-Focused Stores
As Walgreens Preps For New Owner, CVS Health Tries Smaller Drugstores

Share This Article